Michelle I. Rossulek
- Physiology top 10%
- Nutrition and Health in Aging 15
- Rheumatology top 10%
- GDF15 and Related Biomarkers 12
- Geriatrics and Gerontology top 10%
- Frailty in Older Adults 3
-
- Fibroblast Growth Factor Research 2
- Muscle Physiology and Disorders 2
-
- Radiomics and Machine Learning in Medical Imaging 2
-
- Childhood Cancer Survivors' Quality of Life 2
-
- Pharmacogenetics and Drug Metabolism 2
Michelle I. Rossulek
19 papers receiving 818 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Physiology 306
- Rheumatology 156
- Geriatrics and Gerontology 32
- Molecular Biology 483
- Endocrinology, Diabetes and Metabolism 61
Countries citing papers authored by Michelle I. Rossulek
This map shows the geographic impact of Michelle I. Rossulek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle I. Rossulek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle I. Rossulek more than expected).
Fields of papers citing papers by Michelle I. Rossulek
This network shows the impact of papers produced by Michelle I. Rossulek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle I. Rossulek. The network helps show where Michelle I. Rossulek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michelle I. Rossulek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 20 | |
| 5 | Ponsegromab for the Treatment of Cancer Cachexiabreakdown → | 2024 | 97 |
| 6 | 2024 | 12 | |
| 7 | 2023 | 26 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 0 | |
| 13 | 2020 | 115 | |
| 14 | 2020 | 4 | |
| 15 | 2018 | 17 | |
| 16 | A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjectsbreakdown → | 2016 | 406 |
| 17 | 2008 | 21 | |
| 18 | 2003 | 3 | |
| 19 | 2001 | 5 | |
| 20 | 1992 | 5 |
About Michelle I. Rossulek
Michelle I. Rossulek is a scholar working on Rheumatology, Geriatrics and Gerontology and Physiology, having authored 22 papers that have together received 835 indexed citations. Recurring topics across this work include Nutrition and Health in Aging (15 papers), GDF15 and Related Biomarkers (12 papers), Frailty in Older Adults (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Fibroblast Growth Factor Research (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Muscle Physiology and Disorders (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Physiology (306 citations), Rheumatology (156 citations) and Geriatrics and Gerontology (32 citations). Michelle I. Rossulek has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Roberto A. Calle, Jennifer Dong, Veena Somayaji, Tim Rolph, Dongmei Li, Bryan Goodwin, J Chabot, Martin Brenner, Kathryn E. Gropp and Adhiraj Lanba. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.